SPINK1 promotes colorectal cancer progression by downregulating Metallothioneins expression

Colorectal cancer (CRC) is the third most common cancer in the world, and second leading cause of cancer deaths in the US. Although, anti-EGFR therapy is commonly prescribed for CRC, patients harboring mutations in KRAS or BRAF show poor treatment response, indicating an ardent demand for new therap...

Descripción completa

Detalles Bibliográficos
Autores principales: Tiwari, R, Pandey, S K, Goel, S, Bhatia, V, Shukla, S, Jing, X, Dhanasekaran, S M, Ateeq, B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4632074/
https://www.ncbi.nlm.nih.gov/pubmed/26258891
http://dx.doi.org/10.1038/oncsis.2015.23

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4632074/
https://www.ncbi.nlm.nih.gov/pubmed/26258891
http://dx.doi.org/10.1038/oncsis.2015.23

Ejemplares similares